Haemonetics | HAE - Marktkapitalisierung

Aktienkurs
59.19
Täglich Wechseln
-0.37 -0.62%
Monatlich
-7.85%
Jährlich
-3.01%
Q2 Prognose
55.12




Marktkapitalisierung Veränderung Datum
Avanos Medical USD 521M 15M 2025-12
Baxter International USD 9.82B 1.87B 2025-12
Becton, Dickinson and Co. USD 55.29B 1.64B 2025-12
Boston Scientific USD 141.35B 3.31B 2025-12
Cerus USD 286M 36M 2024-12
Cooper Companies USD 15.95B 2.05B 2025-12
Fresenius EUR 27.59B 889.91M 2025-12
Fresenius Medical Care EUR 11.96B 1.14B 2025-12
Globus Medical USD 11.69B 3.95B 2025-12
Haemonetics USD 3.76B 1.44B 2025-12
Hologic USD 16.62B 1.67B 2025-12
ICU Medical USD 3.52B 561M 2025-12
Intuitive Surgical USD 200.77B 40.45B 2025-12
Masimo USD 6.84B 839M 2025-12
Merit Medical Systems USD 5.23B 297M 2025-12
Neogen USD 2.03B 734M 2026-04
OraSure Technologies USD 174M 61M 2025-12
Plus Therapeutics USD 17M 54M 2026-04
Quidel USD 1.99B 66M 2025-12
ResMed USD 35.16B 4.79B 2025-12
STAAR Surgical USD 1.17B 149M 2025-12
Steris USD 24.88B 511M 2025-12
Stryker USD 134.41B 6.92B 2025-12
Teleflex USD 5.39B 91M 2025-12
Thermo Fisher Scientific USD 217.7B 42.4B 2025-12
US Physical Therapy USD 1.19B 105M 2025-12
Zimmer Biomet Holdings USD 17.82B 1.69B 2025-12